Literature DB >> 81905

[Second increase in plasma volume after single infusion of hydroxyethyl starch (author's transl)].

H Köhler, W Kirch, H Pitz.   

Abstract

6 patients without evidence for renal, hepatic or pancreatic disease were treated with intravenous infusions of 500 ml hydroxyethyl starch (6%) over a period of 60 min. In the course of the infusion we observed an increase in plasma volume from 2.72 +/- 0.101 to 3.36 +/- 0.141. After 2 h plasma volume decreased to 3.02 +/- 0.101 but showed a second peak of 3.23 +/- 0.121 after 4 h (p less than 0.01). 24 h following infusion an increase in plasma volume of 4,8% was found as compared to preinfusion values. The second increase in plasma volume cannot be explained by the total concentration of hydroxyethyl starch since the latter decreased continuously. The increase in plasma volume was accompanied by a decrease in average molecular weight (-Mw and -Mn). It is suggested that serum amylase produces small osmotic active molecules by degradation of hydroxyethyl starch, thus leading to an increase in plasma volume. 12--24 h after the infusion of hydroxyethyl starch serum amylase was more than twice as high basal values. This is caused by the formation of a high molecular hydroxyethyl starch-amylase-complex which cannot be eliminated easily. When hydroxyethyl starch is given repeatedly to normovolemic patients, the second increase in plasma volume should be considered as a possible cause for acute hypervolemia. This is especially true for patients with myocardial insufficiency.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 81905     DOI: 10.1007/BF01480153

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  10 in total

1.  Persistence of starch derivatives and dextran when infused after hemorrhage.

Authors:  W L THOMPSON; J J BRITTON; R P WALTON
Journal:  J Pharmacol Exp Ther       Date:  1962-04       Impact factor: 4.030

2.  Determination of amylase activity in biological fluids.

Authors:  H V STREET; J R CLOSE
Journal:  Clin Chim Acta       Date:  1956 May-Jun       Impact factor: 3.786

3.  The body/venous hematocrit ratio: its constancy over a wide hematocrit range.

Authors:  H CHAPLIN; P L MOLLISON; H VETTER
Journal:  J Clin Invest       Date:  1953-12       Impact factor: 14.808

4.  Correction for plasma trapped in the red cell column of the hematocrit.

Authors:  H CHAPLIN; P L MOLLISON
Journal:  Blood       Date:  1952-12       Impact factor: 22.113

5.  [Conservative therapy and peritoneal dialysis in acute pancreatitis].

Authors:  H Köhler; W Kirch; B Roloff; T R Weihrauch; W Prellwitz; D Höffler
Journal:  Verh Dtsch Ges Inn Med       Date:  1976

6.  Studies on the mechanism of aldosterone-induced hypertension in man.

Authors:  A Distler; H J Just; T Philipp
Journal:  Clin Sci Mol Med       Date:  1973-12

7.  Macroamylasaemia after treatment with hydroxyethyl starch.

Authors:  H Köhler; W Kirch; T R Weihrauch; W Prellwitz; H J Horstmann
Journal:  Eur J Clin Invest       Date:  1977-06       Impact factor: 4.686

8.  Autologous and homologous fresh human plasma as a volume expander in hypovolemic subjects.

Authors:  U F Gruber; S E Bergentz
Journal:  Ann Surg       Date:  1967-01       Impact factor: 12.969

9.  [Characterization of clinical dextrans by gel chromatography (author's transl)].

Authors:  H Pitz
Journal:  Anaesthesist       Date:  1975-11       Impact factor: 1.041

10.  [The effect of 6% hydroxyethyl starch, 45% dextran 60 and 5.5% oxy-poly-gelatine on blood volume and circulation in human volunteers (author's transl)].

Authors:  J Kilian; D Spilker; R Borst
Journal:  Anaesthesist       Date:  1975-05       Impact factor: 1.041

  10 in total
  2 in total

1.  Lymphapheresis as compared with rest period in treatment of severe rheumatoid arthritis.

Authors:  A M Boerbooms; D J De Rooy; P J Geerdink; L B Van de Putte; F A Van den Ouweland
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

Review 2.  [Hemodilution and infusion therapy for hypovolemic shock. Clinical physiological and pharmacological aspects].

Authors:  H A Adams
Journal:  Anaesthesist       Date:  2007-04       Impact factor: 1.041

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.